Jameela Jamali, Abdullah Dayo, Yasmeen Qureshi, Tooba Khan, Arshia Adeel, Sania Begum.
A survey on gastrointestinal adverse drug reactions of Doxorubicin and Cyclophosphamide combination therapy.
J Pak Med Assoc Jan ;68(6):926-8.

Adverse drug reactions (ADRs) are very common with anticancer drugs. The objectives of the survey are to evaluate ADRs of AC (Adriamycin (Doxorubicin) and Cyclophosphamide) combination therapy with special reference to GIT (Gastrointestinal system). It was a prospective, descriptive, observational study which included 90 female patients receiving AC combination therapy for their treatment through a purposive sampling and from 01-01-2016 to 31-12-2016 at Cancer Hospital Jamshoro Pakistan. Patients were interviewed during follow up session with a consultant, their response was recorded in a questionnaire and verified through British National formulary (BNF), Hartwig & Siegel scale (ADR severity assessment scale). The survey results shows that AC anticancer combination therapy can result in various disturbances in gastrointestinal tract among which nausea, vomiting decreased appetite and hyperacidity were most common. These must be taken into account and managed with supportive treatment in order to maintain better quality of life during the cancer treatment.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com